Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway

Pulmonary Pharmacology and Therapeutics

Volumn 21, Issue 4, 2008, Pages 595-599

  Moreau Marquis, Sophie ^a   Stanton, Bruce A ^a   O'Toole, George A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Biofilm; Cystic fibrosis; Pseudomonas

Indexed keywords

ACTIN; AZITHROMYCIN; DEOXYRIBONUCLEASE I; F ACTIN; SIALIDASE; TOBRAMYCIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

AEROSOL; AIRWAY; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; BIOFILM; CYSTIC FIBROSIS; DISEASE MARKER; EPITHELIUM CELL; GENETIC DISORDER; GRAM NEGATIVE INFECTION; HUMAN; IN VITRO STUDY; MICROBIAL COMMUNITY; MOLECULAR INTERACTION; MORBIDITY; MORTALITY; MUCUS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; SURFACE PROPERTY; TREATMENT OUTCOME;

ACTINS; ANTI-BACTERIAL AGENTS; BIOFILMS; CYSTIC FIBROSIS; DNA; DRUG RESISTANCE, BACTERIAL; EPITHELIAL CELLS; HUMANS; MUCUS; PSEUDOMONAS AERUGINOSA; SPUTUM;

EID: 47049126626     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2007.12.001     Document Type: Review

References (47)

1. Heijerman H. Infection and inflammation in cystic fibrosis: a short review. J Cyst Fibros 4 Suppl. 2 (2005) 3-5
2. Lyczak J.B., Cannon C.L., and Pier G.B. Lung infections associated with cystic fibrosis. Clin Microbiol Rev 15 (2002) 194-222
3. Fridkin S.K., Steward C.D., Edwards J.R., Pryor E.R., McGowan Jr. J.E., Archibald L.K., et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 29 (1999) 245-252
4. Campana S., Taccetti G., Ravenni N., Masi I., Audino S., Sisi B., et al. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center. J Cyst Fibros 3 (2004) 159-163
5. Pedersen S.S., Koch C., Hoiby N., and Rosendal K. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre. J Antimicrob Chemother 17 (1986) 505-516
6. Jones A.M., Govan J.R., Doherty C.J., Dodd M.E., Isalska B.J., Stanbridge T.N., et al. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 358 (2001) 557-558
7. McCallum S.J., Corkill J., Gallagher M., Ledson M.J., Hart C.A., and Walshaw M.J. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P. aeruginosa. Lancet 358 (2001) 558-560
8. Römling U., Fiedler B., Bosshammer J., Grothues D., Greipel J., von der Hardt H., et al. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. J Infect Dis 170 (1994) 1616-1621
9. Costerton J.W., Stewart P.S., and Greenberg E.P. Bacterial biofilms: a common cause of persistent infections. Science 284 (1999) 1318-1322
10. Worlitzsch D., Tarran R., Ulrich M., Schwab U., Cekici A., Meyer K.C., et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 109 (2002) 317-325
11. Boucher R.C. New concepts of the pathogenesis of cystic fibrosis lung disease. European Respiratory Journal 23 (2004) 146-158
12. Costerton J.W., Lewandowski Z., Caldwell D.E., Korber D.R., and Lappin-Scott H.M. Microbial biofilms. Annu Rev Microbiol 49 (1995) 711-745
13. Matsukawa M., and Greenberg E.P. Putative exopolysaccharide synthesis genes influence Pseudomonas aeruginosa biofilm development. J Bacteriol 186 (2004) 4449-4456
14. Whitchurch C.B., Tolker-Nielsen T., Ragas P.C., and Mattick J.S. Extracellular DNA required for bacterial biofilm formation. Science 295 (2002) 1487
15. Höiby N., Krogh Johansen H., Moser C., Song Z., Ciofu O., and Kharazmi A. Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect 3 (2001) 23-35
16. Lam J., Chan R., Lam K., and Costerton J.W. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun 28 (1980) 546-556
17. Baltimore R.S., Christie C.D., and Smith G.J. Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration. Am Rev Respir Dis 140 (1989) 1650-1661
18. Singh P.K., Schaefer A.L., Parsek M.R., Moninger T.O., Welsh M.J., and Greenberg E.P. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407 (2000) 762-764
19. Heydorn A., Ersbøll B.K., Hentzer M., Parsek M.R., Givskov M., and Molin S. Experimental reproducibility in flow-chamber biofilms. Microbiology 146 (2000) 2409-2415
20. Hassett D.J., Cuppoletti J., Trapnell B., Lymar S.V., Rowe J.J., Yoon S.S., et al. Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets. Adv Drug Deliv Rev 54 (2002) 1425-1443
21. Yoon S.S., Hennigan R.F., Hilliard G.M., Ochsner U.A., Parvatiyar K., Kamani M.C., et al. Pseudomonas aeruginosa anaerobic respiration in biofilms. Relationships to cystic fibrosis pathogenesis. Dev Cell 3 (2002) 593-603
22. Alvarez-Ortega C., and Harwood C.S. Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration. Mol Microbiol 65 (2007) 153-165
23. Fuqua C., Parsek M.R., and Greenberg E.P. Regulation of gene expression by cell-to-cell communication: acyl-homoserine lactone quorum sensing. Annu Rev Genet 35 (2001) 439-468
24. -/- mice. Antimicrob Agents Chemother 51 (2007) 3677-3687
25. Sriramulu D.D., Lunsdorf H., Lam J.S., and Romling U. Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung. J Med Microbiol 54 (2005) 667-676
26. Landry R.M., An D., Hupp J.T., Singh P.K., and Parsek M.R. Mucin-Pseudomonas aeruginosa interactions promote biofilm formation and antibiotic resistance. Mol Microbiol 59 (2006) 142-151
27. Matsui H., Wagner V.E., Hill D.B., Schwab U.E., Rogers T.D., Button B., et al. A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms. Proc Natl Acad Sci USA 103 (2006) 18131-18136
28. Pollard H.B., Ji X.D., Jozwik C., and Jacobowitz D.M. High abundance protein profiling of cystic fibrosis lung epithelial cells. Proteomics 5 (2005) 2210-2226
29. Xu Y., Liu C., Clark J.C., and Whitsett J.A. Functional genomic responses to cystic fibrosis transmembrane conductance regulator (CFTR) and CFTR(delta508) in the lung. J Biol Chem. 281 (2006) 11279-11291
30. Deneuville E., Perrot-Minot C., Pennaforte F., Roussey M., Zahm J.M., Clavel C., et al. Revisited physicochemical and transport properties of respiratory mucus in genotyped cystic fibrosis patients. Am J Respir Crit Care Med 156 (1997) 166-172
31. Allesen-Holm M., Barken K.B., Yang L., Klausen M., Webb J.S., Kjelleberg S., et al. A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Mol Microbiol 59 (2006) 1114-1128
32. Spoering A.L., and Gilmore M.S. Quorum sensing and DNA release in bacterial biofilms. Curr Opin Microbiol 9 (2006) 133-137
33. Walker T.S., Tomlin K.L., Worthen G.S., Poch K.R., Lieber J.G., Saavedra M.T., et al. Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils. Infect Immun 73 (2005) 3693-3701
34. Carterson A.J., Honer zu Bentrup K., Ott C.M., Clarke M.S., Pierson D.L., Vanderburg C.R., et al. A549 lung epithelial cells grown as three-dimensional aggregates: alternative tissue culture model for Pseudomonas aeruginosa pathogenesis. Infect Immun 73 (2005) 1129-1140
35. Haussler S., Ziegler I., Lottel A., von Gotz F., Rohde M., Wehmhohner D., et al. Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection. J Med Microbiol 52 (2003) 295-301
36. Chi E., Mehl T., Nunn D., and Lory S. Interaction of Pseudomonas aeruginosa with A549 pneumocyte cells. Infect Immun 59 (1991) 822-828
37. Garcia-Medina R., Dunne W.M., Singh P.K., and Brody S.L. Pseudomonas aeruginosa acquires biofilm-like properties within airway epithelial cells. Infect Immun 73 (2005) 8298-8305
38. Darling K.E., Dewar A., and Evans T.J. Role of the cystic fibrosis transmembrane conductance regulator in internalization of Pseudomonas aeruginosa by polarized respiratory epithelial cells. Cell Microbiol 6 (2004) 521-533
39. Plotkowski M.C., de Bentzmann S., Pereira S.H., Zahm J.M., Bajolet-Laudinat O., Roger P., et al. Pseudomonas aeruginosa internalization by human epithelial respiratory cells depends on cell differentiation, polarity, and junctional complex integrity. Am J Respir Cell Mol Biol 20 (1999) 880-890
40. Schroeder T.H., Lee M.M., Yacono P.W., Cannon C.L., Gerceker A.A., Golan D.E., et al. CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation. Proc Natl Acad Sci USA 99 (2002) 6907-6912
41. Pier G.R., Grout M., Zaidi T.S., Olsen J.C., Johnson L.G., Yankaskas J.R., et al. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 271 (1996) 64-67
42. Pier G.B., Grout M., and Zaidi T.S. Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc Natl Acad Sci USA 94 (1997) 12088-12093
43. Soong G., Muir A., Gomez M.I., Waks J., Reddy B., Planet P., et al. Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production. J Clin Invest 116 (2006) 2297-2305
44. Lanotte P., Watt S., Mereghetti L., Dartiguelongue N., Rastegar-Lari A., Goudeau A., et al. Genetic features of Pseudomonas aeruginosa isolates from cystic fibrosis patients compared with those of isolates from other origins. J Med Microbiol 53 (2004) 73-81
45. Henke M.O., Renner A., Huber R.M., Seeds M.C., and Rubin B.K. MUC5AC and MUC5B mucins are decreased in Cystic Fibrosis airway secretions. Am J Respir Cell Mol Biol 31 (2004) 86-91
46. Rubin B.K. Mucus structure and properties in cystic fibrosis. Paediatr Respir Rev 8 (2007) 4-7
47. Henke M.O., John G., Germann M., Lindemann H., and Rubin B.K. MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation. Am J Respir Crit Care Med 175 (2007) 816-821